Delving into the Latest Updates on Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine(Novartis Vaccines) with Synapse

Overview

Basic Info

Drug Type

Inactivated vaccine, Prophylactic vaccine, Genetically engineered subunit vaccine

Synonyms-

Target-

Action

stimulants

Mechanism

Immunostimulants

Therapeutic Areas-

Active Indication-

Inactive Indication-

Originator Organization

Novartis Vaccines & Diagnostics, Inc.

Active Organization-

Inactive Organization

Novartis Vaccines & Diagnostics, Inc.

License Organization-

Drug Highest PhasePendingPhase 2/3

First Approval Date-

Regulation-

Login to view timeline

This study is to identify the preferred vaccine dosage (of antigen and adjuvant) and schedule (one or two administrations) of the cell-derived H1N1sw monovalent vaccine in healthy children/adolescents based on European Medicines Agency's Committee for Medicinal Products for Human Use (EMEA/CHMP) criteria, and safety and tolerability.

Start Date01 Oct 2009

Sponsor / Collaborator

Novartis Vaccines & Diagnostics, Inc.

NCT00996138

/ CompletedPhase 2/3

A Multi-center, Randomized, Single-blind, Dose-Ranging Study to Evaluate Immunogenicity, Safety and Tolerability of Different Doses of Adjuvanted Cell-Derived, Inactivated Novel Swine Origin A/H1N1 Monovalent Subunit Influenza Virus Vaccine in Healthy Japanese Adult Subjects

This study is to identify the preferred vaccine dosage (of antigen and adjuvant) and schedule (one or two administrations) of the cell-derived H1N1sw monovalent vaccine in healthy adults based on EMEA/CHMP criteria, and safety & tolerability.

Start Date01 Sep 2009

Sponsor / Collaborator

Novartis Vaccines & Diagnostics, Inc.

100 Clinical Results associated with Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine(Novartis Vaccines)

Login to view more data

100 Translational Medicine associated with Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine(Novartis Vaccines)

Login to view more data

100 Patents (Medical) associated with Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine(Novartis Vaccines)

Login to view more data

100 Deals associated with Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine(Novartis Vaccines)

Login to view more data